Noninferiority of Novel Subcutaneous Infliximab (CT-P13) to Intravenous Infliximab (CT-P13) in Patients with Active Crohn's Disease and Ulcerative Colitis: Week 30 Results from a Multicentre, Randomised Controlled Pivotal Trial
Stefan Schreiber 1
Jaroslaw Leszczyszyn 2
Robert Dudkowiak 2
Adi Lahat 3
Beata Gawdis-Wojnarska 4
Aldis Pukitis 5
Marek Horynski
Katalin Farkas
Jaroslaw KierkuĊ
Maciej Kowalski
Shomron Ben-Horin
Byong Duk Ye
Sang Joon Lee
Sung Hyun Kim
Mi Rim Kim
Han Na Kim
Walter Reinisch
1 University Hospital Schleswig-Holstein,Kiel,Germany
2 Melita Medical,Wroclaw,Poland
3 Chaim Sheba Medical Center and Sackler School of Medicine Tel Aviv University,Ramat Gan,Israel
4 Twoja Przychodnia - Szczecińskie Centrum Medyczne,Szczecin,Poland
5 Pauls Stradins Clinical University Hospital,Riga,
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]